Hodgkin lymphoma

red tape pause delay countdown FDA cancel stop

ADC therapy sidelined after FDA nixes accelerated review chance

ADC Therapeutics has run head-long into the FDA’s new strict policy on accelerated reviews: Get your confirmatory study in line before filing or wait.

Annalee Armstrong Nov 8, 2022 10:25am

visual rendering of an antibody drug conjugate

ADC Therapeutics scores high response for Hodgkin lymphoma drug

Jun 10, 2022 11:27am

ASCO: Takeda Oncology ready to stoke partnerships

Jun 9, 2022 7:30am

New Merck lymphoma data could help patients without options

May 26, 2022 5:00pm